Related Experiment Video
Updated: Jan 12, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.4K
Headway in multiple sclerosis therapy: the case for platinum analogues
Zain Ali Nadeem1, Umar Akram1, Aalaa Saleh2
1Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.
Annals of Medicine and Surgery (2012)
|November 3, 2025
Summary
Carboplatin shows promise for treating multiple sclerosis, a chronic neuroinflammatory disease. Further research is needed to understand its mechanisms and potential adverse effects.
Area of Science:
- Neuroimmunology
- Pharmacology
Background:
- Multiple sclerosis (MS) is a chronic neuroinflammatory condition with significant patient morbidity.
- Existing MS treatments have limitations, including adverse effects.
Purpose of the Study:
- To explore the therapeutic potential of carboplatin, a platinum analog, for multiple sclerosis.
- To review the mechanisms of action and potential adverse effects of carboplatin in MS treatment.
Main Methods:
- Literature review
- Mechanism of action analysis
Main Results:
- Carboplatin demonstrates promising preclinical or early clinical results in multiple sclerosis.
- The review details the proposed mechanisms by which carboplatin may exert therapeutic effects in MS.
- Potential adverse effects associated with carboplatin therapy are identified and discussed.
Conclusions:
- Carboplatin represents a potential novel therapeutic agent for multiple sclerosis.
- Understanding carboplatin's efficacy and safety profile is crucial for its clinical application in MS.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
801
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
801
01:28Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237
01:15Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
01:24Parkinson's Disease: Treatment
963
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
963
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K